Mild atopic dermatitis lacks systemic inflammation and shows reduced nonlesional skin abnormalities
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
BACKGROUND Molecular studies in atopic dermatitis (AD) are largely restricted to patients with moderate-to-severe disease. OBJECTIVE To evaluate skin and blood abnormalities in mild, moderate, and severe AD. METHODS Skin and blood samples were obtained from 61 AD patients (20 mild/limited, 17 moderate, 24 severe) and 20 healthy subjects. Immune and barrier markers were measured in lesional, non-lesional, and healthy skin by qRT-PCR and immunohistochemistry, and in blood using the OLINK proteomic assay. RESULTS Cellular markers of epidermal hyperplasia and T-cell/dendritic cell infiltration were increased in AD tissues of all severity patient groups versus controls, while downstream TH2, TH22, TH1, TH17-related mediators demonstrated incremental elevations with increasing disease severity, in both lesional and non-lesional skin. While TH2 (IL13, CCL17, CCL26) and TH22 (IL-22) cytokines were significantly elevated in both AD lesional and non-lesional skin of all patients regardless of severity, mild/limited AD patients showed increases in TH1 (IFNG, CXCL9, CXCL10) and TH17 (IL-17A, CCL20, CXCL1) markers in lesional, but not non-lesional skin. Treg-related mediators (IL-10, FOXP3) were comparably up-regulated in all groups, without displaying the severity-based gradient in other immune axes. Unsupervised clustering aligned samples along a severity spectrum, where non-lesional mild/limited AD skin clustered with healthy controls. Furthermore, while the blood profiles of moderate and severe AD patients showed gradual increases in TH1/TH2/TH17-related and atherosclerosis/cardiovascular risk (CCL7, FGF21, IGFBP1) proteins, mild/limited AD lacked significant differences versus controls. CONCLUSION Mild/limited AD shows high TH2/TH22 activation primarily localized to skin lesions, and lacks the systemic inflammation of moderate and severe disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Simpson, E. L., Bieber, T., Guttman-Yassky, E., Beck, L. A., Blauvelt, A., Cork, M. J., Silverberg, J. I., Deleuran, M., Kataoka, Y., Lacour, J.-P., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1610020 · Cited by 2,110
Self-citationAssarsson, E., Lundberg, M., Holmquist, G., Björkesten, J., Bucht Thorsen, S., Ekman, D., Eriksson, A., Rennel Dickens, E., Ohlsson, S., Edfeldt, G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095192 · Cited by 1,874
Gittler, J. K., Shemer, A., Suárez-Fariñas, M., Fuentes-Duculan, J., Gulewicz, K. J., Wang, C. Q. F., Mitsui, H., Cardinale, I., de Guzman Strong, C., Krueger, J. G., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.012 · Cited by 981
Self-citationNoda, S., Suárez-Fariñas, M., Ungar, B., Kim, S. J., de Guzman Strong, C., Xu, H., Peng, X., Estrada, Y. D., Nakajima, S., Honda, T., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.08.015 · Cited by 657
Self-citationNograles, K. E., Zaba, L. C., Shemer, A., Fuentes-Duculan, J., Cardinale, I., Kikuchi, T., Ramon, M., Bergman, R., Krueger, J. G., & Guttman-Yassky, E. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.03.041 · Cited by 627
Self-citationSilverberg, J. I., Pinter, A., Pulka, G., Poulin, Y., Bouaziz, J.-D., Wollenberg, A., Murrell, D. F., Alexis, A., Lindsey, L., Ahmad, F., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.08.013 · Cited by 271
Skin barrier defects in atopic dermatitis
Agrawal, R., & Woodfolk, J. A. (2014) · Current Allergy and Asthma Reports · doi:10.1007/s11882-014-0433-9 · Cited by 201
Zhou, L., Leonard, A., Pavel, A. B., Malik, K., Raja, A., Glickman, J., Estrada, Y. D., Peng, X., del Duca, E., Sanz-Cabanillas, J., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.01.015 · Cited by 146
Self-citationKim, H. S., Kim, J. H., Seo, Y. M., Chun, Y. H., Yoon, J.-S., Kim, H. H., Lee, J. S., & Kim, J. T. (2017) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2017.06.022 · Cited by 37
Self-citation
Cited by
Biomarkers in atopic dermatitis—a review on behalf of the International Eczema Council
Renert-Yuval, Y., Thyssen, J. P., Bissonnette, R., Bieber, T., Kabashima, K., Hijnen, D., & Guttman-Yassky, E. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.01.013 · Cited by 350
Self-citationNovel insights into atopic dermatitis
Schuler, C. F., Billi, A. C., Maverakis, E., Tsoi, L. C., & Gudjonsson, J. E. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.10.023 · Cited by 281
Cytokine-Mediated Crosstalk Between Keratinocytes and T Cells in Atopic Dermatitis
Humeau, M., Boniface, K., & Bodet, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.801579 · Cited by 75
Immunological pathomechanisms of spongiotic dermatitis in skin lesions of atopic dermatitis
Tanei, R., & Hasegawa, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126682 · Cited by 33
“However, it is presumed that this is less likely to occur because non-lesioned skin has a relatively well-preserved epidermal barrier function compared to lesioned skin [30,50].”
Background
Metadata
- Authors
- He, H., Del Duca, E., Diaz, A., Kim, H. J., Gay-Mimbrera, J., Zhang, N., Wu, J., Beaziz, J., Estrada, Y., Krueger, J. G., Pavel, A. B., Ruano, J., & Guttman-Yassky, E.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2021-04
- Volume
- 147
- Issue
- 4
- Pages
- 1369-1380
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W3091222502
- Cited by
- 126
- References
- 9
- FWCI
- 10.55
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mild atopic dermatitis lacks systemic inflammation and shows reduced nonlesional skin abnormalities. https://app.cochat.ai/papers/10.1016/j.jaci.2020.08.041
- The paper
- He, H., Del Duca, E., Diaz, A., Kim, H. J., Gay-Mimbrera, J., Zhang, N., Wu, J., Beaziz, J., Estrada, Y., Krueger, J. G., Pavel, A. B., Ruano, J., & Guttman-Yassky, E. (2021). Mild atopic dermatitis lacks systemic inflammation and shows reduced nonlesional skin abnormalities. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2020.08.041
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.